
Brian J. Gangle
Examiner (ID: 511, Phone: (571)272-1181 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1233 |
| Issued Applications | 798 |
| Pending Applications | 132 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14420229
[patent_doc_number] => 10314901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Malaria antigens and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/008852
[patent_app_country] => US
[patent_app_date] => 2018-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16025
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16008852
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/008852 | Malaria antigens and methods of use | Jun 13, 2018 | Issued |
Array
(
[id] => 15931217
[patent_doc_number] => 20200157242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => IMMUNOGLOBULIN COMPOSITIONS AND PROCESS FOR OBTAINING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/621374
[patent_app_country] => US
[patent_app_date] => 2018-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16621374
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/621374 | Immunoglobulin compositions and process for obtaining the same | Jun 11, 2018 | Issued |
Array
(
[id] => 15828577
[patent_doc_number] => 20200129570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => Specific Bacterial Species and Metabolite That Improves Immune Checkpoint Inhibitor Therapy Efficacy
[patent_app_type] => utility
[patent_app_number] => 16/617704
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617704 | Specific Bacterial Species and Metabolite That Improves Immune Checkpoint Inhibitor Therapy Efficacy | May 31, 2018 | Abandoned |
Array
(
[id] => 17058862
[patent_doc_number] => 11103443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Compositions and methods for preventing, slowing, and reversing skin aging
[patent_app_type] => utility
[patent_app_number] => 16/614635
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3867
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614635
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/614635 | Compositions and methods for preventing, slowing, and reversing skin aging | May 21, 2018 | Issued |
Array
(
[id] => 16755372
[patent_doc_number] => 10973900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Dried composition
[patent_app_type] => utility
[patent_app_number] => 16/613111
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16930
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613111
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613111 | Dried composition | May 10, 2018 | Issued |
Array
(
[id] => 16087053
[patent_doc_number] => 20200197513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => NUTRACEUTICAL BLENDS
[patent_app_type] => utility
[patent_app_number] => 16/612637
[patent_app_country] => US
[patent_app_date] => 2018-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612637
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612637 | NUTRACEUTICAL BLENDS | May 9, 2018 | Abandoned |
Array
(
[id] => 13402343
[patent_doc_number] => 20180252714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => System and Method for Identification and Characterization of Transglutaminase Species
[patent_app_type] => utility
[patent_app_number] => 15/974385
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15974385
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/974385 | System and method for identification and characterization of transglutaminase species | May 7, 2018 | Issued |
Array
(
[id] => 14003315
[patent_doc_number] => 10220085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Compositions and methods for detecting, treating, and protecting against
[patent_app_type] => utility
[patent_app_number] => 15/961996
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 21841
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15961996
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/961996 | Compositions and methods for detecting, treating, and protecting against | Apr 24, 2018 | Issued |
Array
(
[id] => 15616101
[patent_doc_number] => 20200078455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => MESOTHELIN VACCINE FOR OVARIAN CANCER PREVENTION
[patent_app_type] => utility
[patent_app_number] => 16/607604
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607604
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607604 | MESOTHELIN VACCINE FOR OVARIAN CANCER PREVENTION | Apr 23, 2018 | Abandoned |
Array
(
[id] => 13369027
[patent_doc_number] => 20180236054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => Tetanus Toxoid and CCL3 Improve DC Vaccines
[patent_app_type] => utility
[patent_app_number] => 15/956909
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15956909
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/956909 | Tetanus toxoid and CCL3 improve DC vaccines | Apr 18, 2018 | Issued |
Array
(
[id] => 14018955
[patent_doc_number] => 20190071471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => Composition for Immunization Against Streptococcus Pneumoniae
[patent_app_type] => utility
[patent_app_number] => 15/953599
[patent_app_country] => US
[patent_app_date] => 2018-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15953599
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/953599 | Composition for Immunization Against Streptococcus Pneumoniae | Apr 15, 2018 | Abandoned |
Array
(
[id] => 13249041
[patent_doc_number] => 10137192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
[patent_app_type] => utility
[patent_app_number] => 15/947820
[patent_app_country] => US
[patent_app_date] => 2018-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 24569
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15947820
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/947820 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Apr 7, 2018 | Issued |
Array
(
[id] => 15363565
[patent_doc_number] => 20200017547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => PROBIOTIC MOLECULES FOR REDUCING PATHOGEN VIRULENCE
[patent_app_type] => utility
[patent_app_number] => 16/494429
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494429
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494429 | Probiotic molecules for reducing pathogen virulence | Mar 15, 2018 | Issued |
Array
(
[id] => 17103228
[patent_doc_number] => 11123419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Methods and compositions for inducing immune responses against Clostridium difficile
[patent_app_type] => utility
[patent_app_number] => 16/494517
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 37
[patent_no_of_words] => 12280
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494517
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494517 | Methods and compositions for inducing immune responses against Clostridium difficile | Mar 14, 2018 | Issued |
Array
(
[id] => 15678417
[patent_doc_number] => 20200093872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => COMPOSITIONS OF OLIGOFRUCTOSE AND COMMENSAL MICROORGANISMS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/494668
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494668
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494668 | Compositions of oligofructose and commensal microorganisms and methods thereof | Mar 13, 2018 | Issued |
Array
(
[id] => 16770890
[patent_doc_number] => 10981979
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Human monoclonal antibodies to
[patent_app_type] => utility
[patent_app_number] => 16/491271
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 22775
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491271
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491271 | Human monoclonal antibodies to | Mar 5, 2018 | Issued |
Array
(
[id] => 18084295
[patent_doc_number] => 11534402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Liquid pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 16/491500
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17236
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491500
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491500 | Liquid pharmaceutical composition | Mar 5, 2018 | Issued |
Array
(
[id] => 18084296
[patent_doc_number] => 11534403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Liquid pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 16/491506
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17177
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491506
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491506 | Liquid pharmaceutical composition | Mar 5, 2018 | Issued |
Array
(
[id] => 12880855
[patent_doc_number] => 20180185460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => METHOD FOR TREATING PREMATURE EJACULATION WITH A BOTULINUM NEUROTOXIN
[patent_app_type] => utility
[patent_app_number] => 15/910417
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15910417
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/910417 | Method for treating premature ejaculation with a botulinum neurotoxin | Mar 1, 2018 | Issued |
Array
(
[id] => 14852187
[patent_doc_number] => 10414805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Gonorrheal MtrE peptides and vaccines
[patent_app_type] => utility
[patent_app_number] => 15/905479
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 16159
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15905479
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/905479 | Gonorrheal MtrE peptides and vaccines | Feb 25, 2018 | Issued |